VACCINE AGAINST MELANOMA

Peptides or proteins which belong to a melanoma-associated antigen are described. These are prepared in large amounts using recombinant DNA techniques and/or chemical synthetic methods. The peptides or proteins can be used as immunogens in vaccine formulations which elicit an immune response able se...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PLOWMAN GREGORY, ESTIN CHARLES D, ROSE TIMOTHY M, PENNATHUR SRIDHAR, HELLSTROM KARL E, PURCHIO ANTHONY, HU SHIU-LOK, BROWN JOSEPH P, HELLSTROM
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PLOWMAN GREGORY
ESTIN CHARLES D
ROSE TIMOTHY M
PENNATHUR SRIDHAR
HELLSTROM KARL E
PURCHIO ANTHONY
HU SHIU-LOK
BROWN JOSEPH P
HELLSTROM
description Peptides or proteins which belong to a melanoma-associated antigen are described. These are prepared in large amounts using recombinant DNA techniques and/or chemical synthetic methods. The peptides or proteins can be used as immunogens in vaccine formulations which elicit an immune response able selectively to destroy melanoma cells in a vaccinated individual. When the peptides or proteins are expressed by a recombinant virus, it is possible to prepare vaccine formulations based on inactivated viruses or based on live viruses. UN METODO PARA PRODUCIR PEPTIDOS ANTIGENICOS PARA VACUNAS RELACIONADOS CON EL ANTIGENO P97 ASOCIADO A MELANOMA, QUE CONTIENE UNA SECUENCIA DE AMINOACIDOS O CUALQUIER PORCION ANTIGENICA DE LA MISMA, CUYO METODO CONSISTE EN (I) COMBINAR UN GRUPO AMINO FIJADO AL CARBONO ALFA DE UN PRIMER AMINOACIDO; (II) ELIMINAR EL GRUPO PROTECTOR UNIDO AL GRUPO AMINO FIJADO AL CARBONO ALFA DEL AMINOACIDO TGERMINAL; (III) COMBINAR EL GRUPO AMINO DEL AMINOACIDO TERMINAL LIBERADO EN LA ETAPA (II) CON UN GRUPO CARBOXILO FIJADO AL CARBONO ALFA DE UN AMINOACIDO; Y (IV) REPETIR LAS ETAPAS (II) Y (III) HASTA QUE SE CONSIGUE UNA CADENA PEPTIDICA DE LA LONGITUD DESEADA.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2017258A6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2017258A6</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2017258A63</originalsourceid><addsrcrecordid>eNrjZJAIc3R29vRzVXB0d_T0Cw5R8HX1cfTz93XkYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrsFGBobmRqYWjmbGRCgBAKisHzM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VACCINE AGAINST MELANOMA</title><source>esp@cenet</source><creator>PLOWMAN GREGORY ; ESTIN CHARLES D ; ROSE TIMOTHY M ; PENNATHUR SRIDHAR ; HELLSTROM KARL E ; PURCHIO ANTHONY ; HU SHIU-LOK ; BROWN JOSEPH P ; HELLSTROM</creator><creatorcontrib>PLOWMAN GREGORY ; ESTIN CHARLES D ; ROSE TIMOTHY M ; PENNATHUR SRIDHAR ; HELLSTROM KARL E ; PURCHIO ANTHONY ; HU SHIU-LOK ; BROWN JOSEPH P ; HELLSTROM</creatorcontrib><description>Peptides or proteins which belong to a melanoma-associated antigen are described. These are prepared in large amounts using recombinant DNA techniques and/or chemical synthetic methods. The peptides or proteins can be used as immunogens in vaccine formulations which elicit an immune response able selectively to destroy melanoma cells in a vaccinated individual. When the peptides or proteins are expressed by a recombinant virus, it is possible to prepare vaccine formulations based on inactivated viruses or based on live viruses. UN METODO PARA PRODUCIR PEPTIDOS ANTIGENICOS PARA VACUNAS RELACIONADOS CON EL ANTIGENO P97 ASOCIADO A MELANOMA, QUE CONTIENE UNA SECUENCIA DE AMINOACIDOS O CUALQUIER PORCION ANTIGENICA DE LA MISMA, CUYO METODO CONSISTE EN (I) COMBINAR UN GRUPO AMINO FIJADO AL CARBONO ALFA DE UN PRIMER AMINOACIDO; (II) ELIMINAR EL GRUPO PROTECTOR UNIDO AL GRUPO AMINO FIJADO AL CARBONO ALFA DEL AMINOACIDO TGERMINAL; (III) COMBINAR EL GRUPO AMINO DEL AMINOACIDO TERMINAL LIBERADO EN LA ETAPA (II) CON UN GRUPO CARBOXILO FIJADO AL CARBONO ALFA DE UN AMINOACIDO; Y (IV) REPETIR LAS ETAPAS (II) Y (III) HASTA QUE SE CONSIGUE UNA CADENA PEPTIDICA DE LA LONGITUD DESEADA.</description><edition>4</edition><language>eng ; spa</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>1991</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19910116&amp;DB=EPODOC&amp;CC=ES&amp;NR=2017258A6$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19910116&amp;DB=EPODOC&amp;CC=ES&amp;NR=2017258A6$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PLOWMAN GREGORY</creatorcontrib><creatorcontrib>ESTIN CHARLES D</creatorcontrib><creatorcontrib>ROSE TIMOTHY M</creatorcontrib><creatorcontrib>PENNATHUR SRIDHAR</creatorcontrib><creatorcontrib>HELLSTROM KARL E</creatorcontrib><creatorcontrib>PURCHIO ANTHONY</creatorcontrib><creatorcontrib>HU SHIU-LOK</creatorcontrib><creatorcontrib>BROWN JOSEPH P</creatorcontrib><creatorcontrib>HELLSTROM</creatorcontrib><title>VACCINE AGAINST MELANOMA</title><description>Peptides or proteins which belong to a melanoma-associated antigen are described. These are prepared in large amounts using recombinant DNA techniques and/or chemical synthetic methods. The peptides or proteins can be used as immunogens in vaccine formulations which elicit an immune response able selectively to destroy melanoma cells in a vaccinated individual. When the peptides or proteins are expressed by a recombinant virus, it is possible to prepare vaccine formulations based on inactivated viruses or based on live viruses. UN METODO PARA PRODUCIR PEPTIDOS ANTIGENICOS PARA VACUNAS RELACIONADOS CON EL ANTIGENO P97 ASOCIADO A MELANOMA, QUE CONTIENE UNA SECUENCIA DE AMINOACIDOS O CUALQUIER PORCION ANTIGENICA DE LA MISMA, CUYO METODO CONSISTE EN (I) COMBINAR UN GRUPO AMINO FIJADO AL CARBONO ALFA DE UN PRIMER AMINOACIDO; (II) ELIMINAR EL GRUPO PROTECTOR UNIDO AL GRUPO AMINO FIJADO AL CARBONO ALFA DEL AMINOACIDO TGERMINAL; (III) COMBINAR EL GRUPO AMINO DEL AMINOACIDO TERMINAL LIBERADO EN LA ETAPA (II) CON UN GRUPO CARBOXILO FIJADO AL CARBONO ALFA DE UN AMINOACIDO; Y (IV) REPETIR LAS ETAPAS (II) Y (III) HASTA QUE SE CONSIGUE UNA CADENA PEPTIDICA DE LA LONGITUD DESEADA.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1991</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAIc3R29vRzVXB0d_T0Cw5R8HX1cfTz93XkYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrsFGBobmRqYWjmbGRCgBAKisHzM</recordid><startdate>19910116</startdate><enddate>19910116</enddate><creator>PLOWMAN GREGORY</creator><creator>ESTIN CHARLES D</creator><creator>ROSE TIMOTHY M</creator><creator>PENNATHUR SRIDHAR</creator><creator>HELLSTROM KARL E</creator><creator>PURCHIO ANTHONY</creator><creator>HU SHIU-LOK</creator><creator>BROWN JOSEPH P</creator><creator>HELLSTROM</creator><scope>EVB</scope></search><sort><creationdate>19910116</creationdate><title>VACCINE AGAINST MELANOMA</title><author>PLOWMAN GREGORY ; ESTIN CHARLES D ; ROSE TIMOTHY M ; PENNATHUR SRIDHAR ; HELLSTROM KARL E ; PURCHIO ANTHONY ; HU SHIU-LOK ; BROWN JOSEPH P ; HELLSTROM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2017258A63</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>1991</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>PLOWMAN GREGORY</creatorcontrib><creatorcontrib>ESTIN CHARLES D</creatorcontrib><creatorcontrib>ROSE TIMOTHY M</creatorcontrib><creatorcontrib>PENNATHUR SRIDHAR</creatorcontrib><creatorcontrib>HELLSTROM KARL E</creatorcontrib><creatorcontrib>PURCHIO ANTHONY</creatorcontrib><creatorcontrib>HU SHIU-LOK</creatorcontrib><creatorcontrib>BROWN JOSEPH P</creatorcontrib><creatorcontrib>HELLSTROM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PLOWMAN GREGORY</au><au>ESTIN CHARLES D</au><au>ROSE TIMOTHY M</au><au>PENNATHUR SRIDHAR</au><au>HELLSTROM KARL E</au><au>PURCHIO ANTHONY</au><au>HU SHIU-LOK</au><au>BROWN JOSEPH P</au><au>HELLSTROM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VACCINE AGAINST MELANOMA</title><date>1991-01-16</date><risdate>1991</risdate><abstract>Peptides or proteins which belong to a melanoma-associated antigen are described. These are prepared in large amounts using recombinant DNA techniques and/or chemical synthetic methods. The peptides or proteins can be used as immunogens in vaccine formulations which elicit an immune response able selectively to destroy melanoma cells in a vaccinated individual. When the peptides or proteins are expressed by a recombinant virus, it is possible to prepare vaccine formulations based on inactivated viruses or based on live viruses. UN METODO PARA PRODUCIR PEPTIDOS ANTIGENICOS PARA VACUNAS RELACIONADOS CON EL ANTIGENO P97 ASOCIADO A MELANOMA, QUE CONTIENE UNA SECUENCIA DE AMINOACIDOS O CUALQUIER PORCION ANTIGENICA DE LA MISMA, CUYO METODO CONSISTE EN (I) COMBINAR UN GRUPO AMINO FIJADO AL CARBONO ALFA DE UN PRIMER AMINOACIDO; (II) ELIMINAR EL GRUPO PROTECTOR UNIDO AL GRUPO AMINO FIJADO AL CARBONO ALFA DEL AMINOACIDO TGERMINAL; (III) COMBINAR EL GRUPO AMINO DEL AMINOACIDO TERMINAL LIBERADO EN LA ETAPA (II) CON UN GRUPO CARBOXILO FIJADO AL CARBONO ALFA DE UN AMINOACIDO; Y (IV) REPETIR LAS ETAPAS (II) Y (III) HASTA QUE SE CONSIGUE UNA CADENA PEPTIDICA DE LA LONGITUD DESEADA.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_ES2017258A6
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
TESTING
VINEGAR
WINE
title VACCINE AGAINST MELANOMA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T10%3A43%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PLOWMAN%20GREGORY&rft.date=1991-01-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2017258A6%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true